These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 15482324

  • 1. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH, Lin YS, Lin CC, Yang YH, Ho YP, Tsai CC.
    J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
    [Abstract] [Full Text] [Related]

  • 2. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study.
    Streckfus C, Bigler L, Dellinger T, Dai X, Kingman A, Thigpen JT.
    Clin Cancer Res; 2000 Jun; 6(6):2363-70. PubMed ID: 10873088
    [Abstract] [Full Text] [Related]

  • 3. ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients.
    Meenakshi A, Kumar RS, Kumar NS.
    J Immunoassay Immunochem; 2002 Jun; 23(3):293-305. PubMed ID: 12227416
    [Abstract] [Full Text] [Related]

  • 4. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma.
    Zhong LP, Zhu HG, Zhang CP, Chen WT, Zhang ZY.
    Int J Oral Maxillofac Surg; 2007 Mar; 36(3):230-4. PubMed ID: 16965897
    [Abstract] [Full Text] [Related]

  • 5. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ, Li JR, Li ZB.
    Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
    [Abstract] [Full Text] [Related]

  • 6. Studies of the serum HER-2/neu and squamous cell carcinoma-related antigen expression in patients with oral squamous cell carcinoma.
    Chen CH, Tsai TL, Yang YS, Tsai CC.
    J Oral Pathol Med; 2007 Feb; 36(2):83-7. PubMed ID: 17238969
    [Abstract] [Full Text] [Related]

  • 7. The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome.
    Papadopoulou E, Tripsianis G, Anagnostopoulos K, Tentes I, Kakolyris S, Galazios G, Sivridis E, Simopoulos K, Kortsaris A.
    Neoplasma; 2008 Feb; 55(2):113-21. PubMed ID: 18237248
    [Abstract] [Full Text] [Related]

  • 8. The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer.
    Schippinger W, Regitnig P, Bauernhofer T, Ploner F, Hofmann G, Krippl P, Wehrschütz M, Lax S, Carney W, Neumann R, Wernecke KD, Samonigg H.
    Oncol Rep; 2004 Jun; 11(6):1331-6. PubMed ID: 15138574
    [Abstract] [Full Text] [Related]

  • 9. Serial serum c-erbB-2 levels in patients with breast carcinoma.
    Volas GH, Leitzel K, Teramoto Y, Grossberg H, Demers L, Lipton A.
    Cancer; 1996 Jul 15; 78(2):267-72. PubMed ID: 8674002
    [Abstract] [Full Text] [Related]

  • 10. Serum soluble CD44v6 levels in patients with oral and maxillofacial malignancy.
    Chang SM, Xing RD, Zhang FM, Duan YQ.
    Oral Dis; 2009 Nov 15; 15(8):570-2. PubMed ID: 19563418
    [Abstract] [Full Text] [Related]

  • 11. Serum c-erbB-2 protein in breast cancer patients.
    Chearskul S, Sinlarat P, Bhothisuwan K, Churintrapun M, Ornrhebroi S, Klinsala N, Sungkabunchoo S.
    J Med Assoc Thai; 2000 Aug 15; 83(8):886-93. PubMed ID: 10998842
    [Abstract] [Full Text] [Related]

  • 12. [Serum her-2/neu level and related factors in patients with breast cancer].
    Yuan P, Xu BH, Zhang C, Qi J.
    Zhonghua Zhong Liu Za Zhi; 2003 Nov 15; 25(6):573-4. PubMed ID: 14690565
    [Abstract] [Full Text] [Related]

  • 13. erbB-2 and myc oncoproteins in sera and tumors of breast cancer patients.
    Breuer B, De Vivo I, Luo JC, Smith S, Pincus MR, Tatum AH, Daucher J, Minick CR, Miller DG, Nowak EJ.
    Cancer Epidemiol Biomarkers Prev; 1994 Nov 15; 3(1):63-6. PubMed ID: 7906981
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E, Anagnostopoulos K, Tripsianis G, Tentes I, Kakolyris S, Galazios G, Sivridis E, Simopoulos K, Kortsaris A.
    Neoplasma; 2008 Nov 15; 55(3):229-38. PubMed ID: 18348656
    [Abstract] [Full Text] [Related]

  • 15. Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients.
    Tamaki S, Sanefuzi N, Kawakami M, Aoki K, Imai Y, Yamanaka Y, Yamamoto K, Ishitani A, Hatake K, Kirita T.
    Hum Immunol; 2008 Feb 15; 69(2):88-93. PubMed ID: 18361932
    [Abstract] [Full Text] [Related]

  • 16. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma.
    Xia W, Lau YK, Zhang HZ, Liu AR, Li L, Kiyokawa N, Clayman GL, Katz RL, Hung MC.
    Clin Cancer Res; 1997 Jan 15; 3(1):3-9. PubMed ID: 9815530
    [Abstract] [Full Text] [Related]

  • 17. Detection of p105 (c-erbB-2, HER2/neu) serum levels by a new ELISA in patients with ovarian carcinoma.
    Marx D, Fattahi-Meibodi A, Kudelka R, Uebel T, Kuhn W, Meden H.
    Anticancer Res; 1998 Jan 15; 18(4B):2891-4. PubMed ID: 9713482
    [Abstract] [Full Text] [Related]

  • 18. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
    Zhong LP, Zhang CP, Zheng JW, Li J, Chen WT, Zhang ZY.
    Arch Oral Biol; 2007 Nov 15; 52(11):1079-87. PubMed ID: 17612501
    [Abstract] [Full Text] [Related]

  • 19. Tissue and serum c-erbB-2 and tissue EGFR in breast carcinoma: three years follow-up.
    Mansour OA, Zekri AR, Harvey J, Teramoto Y, el-Ahmady O.
    Anticancer Res; 1997 Nov 15; 17(4B):3101-6. PubMed ID: 9329611
    [Abstract] [Full Text] [Related]

  • 20. Correlations of chronic hepatitis B virus infection and cigarette smoking with elevated expression of neu oncoprotein in the development of hepatocellular carcinoma.
    Yu MW, Chen CJ, Luo JC, Brandt-Rauf PW, Carney WP, Santella RM.
    Cancer Res; 1994 Oct 01; 54(19):5106-10. PubMed ID: 7923126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.